Australia markets closed

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.2400-0.3100 (-6.81%)
At close: 04:00PM EDT
4.2800 +0.04 (+0.94%)
After hours: 07:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
21,281
35,642
-8,627
11,989
Depreciation & amortisation
7,461
12,024
3,760
3,538
Deferred income taxes
-5,828
-8,324
-3,618
-1,511
Stock-based compensation
17,014
16,451
19,555
24,756
Change in working capital
-40,693
-16,404
9,537
816
Accounts receivable
-51,139
-30,832
9,529
-3,113
Inventory
-27,599
-8,339
-13,833
-1,509
Accounts payable
-111
2,966
10,162
806
Other working capital
21,008
50,523
27,896
48,750
Other non-cash items
2,379
1,449
2,128
4,609
Net cash provided by operating activities
21,225
50,701
28,219
49,497
Cash flows from investing activities
Investments in property, plant and equipment
-217
-178
-323
-747
Acquisitions, net
1,264
-74,152
0
0
Purchases of investments
-12,500
-12,500
0
-17,500
Other investing activities
-
-
-5,000
-
Net cash used for investing activities
-86,870
-86,830
-5,323
-18,247
Cash flows from financing activities
Debt repayment
-8,000
-67,236
-8,000
-115,000
Common stock repurchased
-26,649
-18,004
-21,213
-34,999
Other financing activities
-1,367
-2,716
-1,577
-1,525
Net cash used provided by (used for) financing activities
-18,712
-6,209
-28,392
-37,870
Net change in cash
-84,357
-42,338
-5,496
-6,620
Cash at beginning of period
99,741
97,659
103,155
109,775
Cash at end of period
15,384
55,321
97,659
103,155
Free cash flow
Operating cash flow
21,225
50,701
28,219
49,497
Capital expenditure
-217
-178
-323
-747
Free cash flow
21,008
50,523
27,896
48,750